Immunotherapy
Researchers' work from Cornell University focuses on immunotherapy
Published in Cancer Weekly, September 4th, 2007
Investigators publish new data in the report "Phase 1/2 clinical trial of interferon alpha2b and weekly liposome-encapsulated all-trans retinoic acid in patients with advanced renal cell carcinoma." In this recent report, researchers in the United States conducted a study "To evaluate the feasibility, efficacy, and biologic effects of weekly liposome-encapsulated all-trans retinoic acid (ATRA-IV) plus interferon alpha2b (IFN) in patients with advanced renal cell carcinoma (RCC). Twenty-six patients with metastatic RCC were treated on a phase 1/2 trial with weekly ATRA-IV and IFN SQ daily 5 d/wk."
"Twelve patients received ATRA-IV at three dose levels (60, 75, and 90...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2007-09-04)
More Articles from Cancer Weekly
- Biomedicine
The St. Baldrick's Foundation Awards $4.5 Million Grant to the Children's Oncology Group - Bladder Cancer
Bioniche Provides Update on Refractory Bladder Cancer Trial - Breast Cancer
Chicago Cubs, National City Searching for Breast Cancer Survivors To Honor Before Cubs vs. Pirates Home Game - Breast Cancer
Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge) in Advanced Breast Cancer Patients - Breast Cancer
Des Moines Affiliate of Susan G. Komen for the Cure, Elizabeth Edwards, Breast Cancer Survivors and Activists Called on Policymakers to Address Injustice and Unfairness in Breast Cancer Incidence and Mortality - Breast Cancer
Fat bastard Wine Wears Pink Ribbon in Support of Breast Cancer - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
